Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
Tags
Tyson Foods Inc
U/S/ Markets
stocks
From
CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
December 02, 2023
Tags
Novo Nordisk A/S
Abbott Laboratories
Science
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Pfizer Inc
Business News
Clinical trials
From
CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
Tags
Novo Nordisk A/S
Business
Biotechnology
From
CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
Tags
Business News
Pharmaceuticals
Breaking news
From
CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
Tags
Investment strategy
stocks
Business News
From
CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
Tags
Business
Biotechnology
Eli Lilly and Co
From
CNBC.com News
5 things to know before the stock market opens Monday
November 13, 2023
Tags
5 Things to Know
Business News
Economy
From
CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
November 11, 2023
Tags
Business News
Novo Nordisk A/S
Business
From
CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
Salesforce Inc
Investing
ServiceNow Inc
From
CNBC.com News
Cramer's Lightning Round: Buy AutoZone
November 09, 2023
Tags
Investment Strategy
Autozone Inc
Broadcom Inc
From
CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
Tags
Health & Science
Companies
Health care industry
From
CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
November 02, 2023
Tags
Companies
Health care industry
Health & Science
From
CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
November 02, 2023
Tags
Eli Lilly and Co
Business
Biotechnology
From
CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
November 02, 2023
Tags
Novo Nordisk A/S
Europe News
Business News
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Business News
Earnings
Breaking News: Earnings
From
CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
October 31, 2023
Tags
Novo Nordisk A/S
Spin/offs
Business
From
CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
Tags
Apple Inc
Breaking News: Technology
Weight management
From
CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
October 24, 2023
Tags
World Markets
Prices
Tesla Inc
From
CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
Tags
Consumer prices
Novo Nordisk A/S
Markets
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Breaking News: Investing
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
Walgreens Boots Alliance Inc
Novo Nordisk A/S
Health & Science
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Markets
Exercise
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
October 13, 2023
Tags
Novo Nordisk A/S
Biotechnology
Business
From
CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 11, 2023
Tickers
BIRK
EVS
MSFT
NVO
Tags
NVO
News
Novo Nordisk
From
Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
Tags
stocks
Mad Money
Business News
From
CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
Tags
Plug Power Inc
Finance
stocks
From
CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
October 11, 2023
Tags
CSX Corp
Market Insider
Business
From
CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
October 11, 2023
Tags
Novo Nordisk A/S
Europe Markets
LVMH Moet Hennessy Louis Vuitton SE
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Consumer Finance
Pharmaceuticals
Diabetes
From
CNBC.com News
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.